Biogen Reports Record Third Quarter 2016 Revenues of $3.0 Billion
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St set for tepid open as oil prices fall, Treasury yields rise
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Biogen (BIIB) Tops Q3 EPS by 22c
October 26, 2016 7:00 AM EDTBiogen (NASDAQ: BIIB) reported Q3 EPS of $5.19, $0.22 better than the analyst estimate of $4.97. Revenue for the quarter came in at $2.96 billion versus the consensus estimate of $2.91 billion.
Eloctate revenue $131.8 million, est. $131.2 million.
Alprolix revenue $85.2 million, est. $86.2 million.
For earnings history and earnings-related data on Biogen (BIIB) click here.
... More